Type1diabetes study: CB Sleep
Official title Health Behavior Intervention for Adults With Type 1 Diabetes
ClinicalTrials.gov ID: NCT05823142
What this study is testing
- What it's testing
- This study is testing whether a 12‑week sleep health program improves sleep and diabetes self‑management in young adults with type 1 diabetes.
- Who it's for
- You may be able to join if you are 18‑31 years old, have type 1 diabetes, and are not meeting blood‑sugar targets.
- What's involved
- You would take part in a 12‑week program that teaches better sleep habits through phone or video sessions. You will wear a sleep tracker and answer short surveys about your sleep and diabetes.
- Time commitment
- The study lasts about 9 months, with weekly sessions during the 12‑week program and later check‑ins.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Aged 18 to 40 years
- Type 1 Diabetes at least 1 year
- One or more sleep health dimension out of range
You likely can't join if
- Non-English speaking
- A1C \ 80% time in glucose range
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.